Interlink is a binary micro-cap turnaround: a proposed profitable acquisition and medical printed-electronics pipeline could transform the business, but execution, dilution, customer concentration, and China-linked supply risk define the downside.
Overview
Interlink Electronics is attempting a high-stakes transformation from a sub-scale, loss-making micro-cap sensor supplier into a diversified printed electronics and high-performance manufacturing platform. The central catalyst is a proposed acquisition of a $33M revenue, $4M EBITDA target that could lift pro-forma revenue above $45M and establish profitability. Organic upside comes from medical test-strip electrodes, smart textiles, and gas sensors. Q1 2026 showed improving revenue and margins, while preferred stock conversion and Russell Microcap inclusion improve capital-market visibility. Execution, financing, integration, and commercialization remain decisive risks.